Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

11.9K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.9K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.2K
4.2K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

1.5K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.5K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

785
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
785
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia01:16

Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia

1.5K
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells.

Science advances·2026
Same author

Metabolic Profiling Identifies Infertile Men at Risk of Accelerated Aging: Implications for Systemic and Reproductive Health.

Andrology·2026
Same author

CXCR6+ CD127- Tr1 cells balance immunity and persistence in Plasmodium falciparum infection.

The Journal of clinical investigation·2026
Same author

Antigen-specific B cell response regulation by IL-10-producing tolerogenic dendritic cells.

Science advances·2025
Same author

Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions.

Molecular therapy. Methods & clinical development·2025
Same author

CXCR6<sup>+</sup> CD127<sup>-</sup> Tr1 Cells Balance Immunity and Persistence in Plasmodium falciparum Infection.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Feb 13, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.7K

Engineered T Regulatory Type 1 Cells for Clinical Application.

Silvia Gregori1, Maria Grazia Roncarolo2

  • 1San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.

Frontiers in Immunology
|March 3, 2018
PubMed
Summary

Regulatory type 1 (Tr1) cells modulate immune responses and show promise in cell therapy. Protocols for generating Tr1 cells in vitro are advancing clinical applications for immune-mediated diseases.

Keywords:
IL-10T regulatory cell-based therapyT regulatory type 1 (Tr1) cellsgene transfertolerance

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K
Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.8K

Related Experiment Videos

Last Updated: Feb 13, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

11.7K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K
Experimental Approaches to Tissue Engineering
16:41

Experimental Approaches to Tissue Engineering

Published on: August 30, 2007

6.8K

Area of Science:

  • Immunology
  • Cell Therapy
  • Regulatory T cells

Background:

  • T regulatory cells (Tregs) are crucial for immune response modulation.
  • Inducible T regulatory type 1 (Tr1) cells secrete IL-10 and TGF-β, and kill myeloid cells via granzyme B (GzB).
  • Tr1 cells have demonstrated efficacy in modulating immune-mediated diseases.

Purpose of the Study:

  • To review protocols for in vitro induction and expansion of Tr1 cells for clinical use.
  • To summarize results from Tr1 cell-based clinical trials.
  • To discuss a novel protocol for converting CD4+ T cells into Tr1-like cells using lentiviral IL-10 gene transfer.

Main Methods:

  • Review of established clinical-grade protocols for Tr1 cell generation and expansion.
  • Analysis of data from proof-of-concept clinical trials involving Tr1 cell products.
  • Description of a lentiviral vector-mediated IL-10 gene transfer method for Tr1-like cell generation.

Main Results:

  • Clinical trials indicate Tr1 cell therapy is safe, feasible, and offers potential clinical benefits.
  • Established protocols allow for the generation and expansion of Tr1 cells in vitro for therapeutic purposes.
  • A new protocol efficiently converts human CD4+ T cells into Tr1-like cells.

Conclusions:

  • Tr1 cell therapy is a promising approach for immune-mediated diseases.
  • In vitro generation and expansion protocols are key to clinical application.
  • Lentiviral IL-10 gene transfer offers a novel strategy for Tr1-like cell generation.